Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | VNN1 | O95497 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | CD74 | P04233 | 1/20 | 0.38 |
| ▸ | MIF | P14174 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6131012 | 0.85 | CYP1A2 (0.40) | ALDH1A1CYP1A2L3MBTL1CHRM1HRH1 | |
| SCHEMBL3076036 | 0.84 | CYP1A2 (0.47) | ALDH1A1CYP1A2VNN1CHRM1HRH1 | |
| SCHEMBL28210941 | 0.82 | CYP1A2 (0.38) | ALDH1A1CYP1A2L3MBTL1VNN1CHRM1 | |
| SCHEMBL29349000 | 0.82 | ESR1 (0.48) | ALDH1A1CYP1A2L3MBTL1TAAR1CD74 | |
| SCHEMBL28188196 | 0.81 | KCNH2 (0.57) | ALDH1A1CYP1A2VNN1MAOBCES1 | |
| SCHEMBL24662607 | 0.77 | MAOB (0.43) | CYP1A2L3MBTL1MAOBRAB9ASMN1; SMN2 | |
| SCHEMBL29182424 | 0.77 | TAAR1 (0.46) | ALDH1A1HRH1KCNH2TAAR1CYP2D6 | |
| SCHEMBL30861999 | 0.77 | TAAR1 (0.46) | ALDH1A1HRH1KCNH2TAAR1CYP2D6 | |
| SCHEMBL29076301 | 0.77 | CYP2D6 (0.46) | CYP1A2TAAR1HTR2CCYP2D6 | |
| SCHEMBL28174339 | 0.77 | LTA4H (0.52) | ALDH1A1RAB9ASMN1; SMN2MIFLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024078365-A1 | HERBICIDAL COMPOSITION COMPRISING 3-(2-CHLORO-4-FLUORO-5-(3-METHYL-2,6-DIOXO-4-TRIFLUOROMETHYL-3,6-DIHYDROPYRIMIDINE-1(2H)-YL)PHENYL)-5-METHYL-4,5-DIHYDROISOXAXOLE-5-CABOXYLIC ACID ETHYL ESTER AND GLUFOSINATE-P AND USE THEREOF | 南通江山农药化工股份有限公司 | 2024-04-18 | — | — | WO | claimed |
| US-20160102184-A1 | MICROPOROUS POLYIMIDE SPONGE AND METHOD FOR PRODUCING THE SAME | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2016-04-14 | — | — | US | claimed |
| WO-1999018082-A1 | NOVEL SUBSTITUTED PYRIDAZINONES | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-15 | — | — | WO | claimed |
| WO-2024078365-A1 | HERBICIDAL COMPOSITION COMPRISING 3-(2-CHLORO-4-FLUORO-5-(3-METHYL-2,6-DIOXO-4-TRIFLUOROMETHYL-3,6-DIHYDROPYRIMIDINE-1(2H)-YL)PHENYL)-5-METHYL-4,5-DIHYDROISOXAXOLE-5-CABOXYLIC ACID ETHYL ESTER AND GLUFOSINATE-P AND USE THEREOF | 南通江山农药化工股份有限公司 | 2024-04-18 | — | — | WO | disclosed |
| US-10442894-B2 | Microporous polyimide sponge and method for producing the same | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2019-10-15 | — | — | US | disclosed |
| US-20170298185-A1 | MICROPOROUS POLYIMIDE SPONGE AND METHOD FOR PRODUCING THE SAME | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2017-10-19 | — | — | US | disclosed |
| US-20160102184-A1 | MICROPOROUS POLYIMIDE SPONGE AND METHOD FOR PRODUCING THE SAME | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2016-04-14 | — | — | US | disclosed |
| EP-2220073-B1 | PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS | MSD ITALIA SRL (IT) | 2014-09-03 | — | — | EP | disclosed |
| CN-101855221-B | Pyridazinone derivatives as PARP inhibitors | ANGELETTI P IST RICHERCHE BIO | 2013-10-30 | — | — | CN | disclosed |
| US-8541380-B2 | C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same | GREEN CROSS CORPORATION (KR) | 2013-09-24 | — | — | US | disclosed |
| EP-2515657-A1 | TYROSINE KINASE INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2012-10-31 | — | — | EP | disclosed |
| US-20050239786-A1 | Triazole derivatives as tachykinin receptor antagonists | ELI LILLY COMPANY (US) | 2005-10-27 | — | — | US | disclosed |
| CN-1646502-A | Triazole derivatives as tachykinin receptor antagonists | LILLY CO ELI (US) | 2005-07-27 | — | — | CN | disclosed |
| EP-1501809-A1 | TRIAZOLE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2005-02-02 | — | — | EP | disclosed |
| WO-2004085406-A1 | BENZYL-PYRIDAZINONS AS REVERSE TRANSCRIPTASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-10-07 | — | — | WO | disclosed |
| EP-1194411-B1 | BENZOYLPYRIDAZINES | MERCK PATENT GMBH (DE) | 2004-06-16 | — | — | EP | disclosed |
| CN-1505635-A | Synthesis method of 2 ', 3' -dideoxy-2 ', 3' -didehydronucleoside | — | 2004-06-16 | — | — | CN | disclosed |
| WO-2003091226-A1 | TRIAZOLE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2003-11-06 | — | — | WO | disclosed |
| EP-1194411-A1 | BENZOYLPYRIDAZINES | MERCK PATENT GmbH (DE) | 2002-04-10 | — | — | EP | disclosed |
| WO-2001004099-A1 | BENZOYLPYRIDAZINES | MERCK PATENT GMBH (DE) | 2001-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239786-A1 | Triazole derivatives as tachykinin receptor antagonists | TACR1, TACR2, BDKRB1 | ALDH1A1 1408/4885CALM1 2143/4885CYP1A2 2348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.